Evidence map›Paper›PMID 37456993›Full record

ArticleFrontiers in neuroscience2023

TIMP3 promotes the maintenance of neural stem-progenitor cells in the mouse subventricular zone.

Lingyan Fang, Takaaki Kuniya, Yujin Harada, Osamu Yasuda, Nobuyo Maeda, Yutaka Suzuki, Daichi Kawaguchi, Yukiko Gotoh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lingyan FangGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Takaaki KuniyaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Yujin HaradaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Osamu YasudaDepartment of Sports and Life Sciences, National Institute of Fitness and Sports in Kanoya, Kanoya, Japan.
Nobuyo MaedaDepartment of Sports and Life Sciences, National Institute of Fitness and Sports in Kanoya, Kanoya, Japan.
Yutaka SuzukiDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
Daichi KawaguchiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Yukiko GotohGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNational Institute of Fitness and Sports in Kanoya · JP

Funding

MODELS FOR STUDYING THE GENETICS OF HYPERTENSIONR01HL049277 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 1992 to 2025
$17.5M
Testing Human Quantitative Genomic Variations in MiceR01HL077145 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 2005 to 2009
$1.8M
NHLBI NIH HHS R01 HL049277NHLBI NIH HHS R01 HL077145
6 · The paper itself

Abstract

Adult neural stem cells (NSCs) in the mouse subventricular zone (SVZ) serve as a lifelong reservoir for newborn olfactory bulb neurons. Recent studies have identified a slowly dividing subpopulation of embryonic neural stem-progenitor cells (NPCs) as the embryonic origin of adult NSCs. Yet, little is known about how these slowly dividing embryonic NPCs are maintained until adulthood while other NPCs are extinguished by the completion of brain development. The extracellular matrix (ECM) is an essential component of stem cell niches and thus a key determinant of stem cell fate. Here we investigated tissue inhibitors of metalloproteinases (TIMPs)-regulators of ECM remodeling-for their potential roles in the establishment of adult NSCs. We found that

Indexed as

adult neural stem cellembryonic neural stem-progenitor cellnotch signalingstem cell maintenanceTIMP3

Identifiers

PMID37456993
PMCPMC10338847
OpenAlexW4382393532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.